期刊文献+

25-羟-维生素D与类风湿患者骨质疏松的相关性分析 被引量:8

Correlation between 25-hydroxy-vitamin D levels with rheumatoid osteoporosis
下载PDF
导出
摘要 目的探讨25-羟-维生素D(25OHD)水平与类风湿患者骨质疏松的相关性并分析其临床意义。方法选择类风湿患者98例,根据类风湿病情活动性评分(DAS28评分),将所有患者分为稳定组(51例)和活动组(47例),分别进行25OHD和骨密度测定,并进行双手X光片检查。结果活动组患者25OHD水平较稳定组显著下降(P<0.05),活动组全髋骨密度、股骨颈骨密度值较稳定组显著下降(P<0.05),活动组腰椎(L1~L4)虽较稳定组下降,但无统计学差异(P>0.05),25OHD与L1~L4骨密度无明显相关性,与全髋及股骨颈骨密度呈显著正相关(P<0.05,P<0.01),25OHD与骨侵蚀及骨狭窄的Sharp评分呈显著负相关(P<0.01,P<0.05)。结论 25OHD有助于评估类风湿患者骨质疏松病情且与骨质疏松程度及类风湿病情活动程度密切相关。 Objective To investigate the correlation between 25 - hydroxy - vitamin D(25OHD) levels with rheumatoid osteopo- rosis and its clinical significance. Methods 98 cases of rheumatoid patients were divided into stable groups(51 cases) and active group(47 cases )according to DAS28 score. 25OHD,bone density and hands X-ray film examination were determined. Results In patients of active group, 25OHD was significantly decreased, compared with that of stable group(P〈0.05), bone density of the to- tal hip and femoral neck BMD ih active group were also significantly lower than those in stable group(P〈0.05), bone density of lumbar spine(L1-L4) in active group was not with significant difference with stable group(P〈0.05). 25OHD and L1-L4 bone den- sity were significantly positively correlated with total hip and femoral neck(P〈0.05,P〈0.01) ,and 25OHD were negatively corre- lated with bone erosion and bone narrow Sharp score(P〈0.01 ,P〈0.05). Conclusion 25OHD could contribute to the assessment of patients with rheumatoid osteoporosis and might be closely related to the degree of osteoporosis and the degree of rheumatoid activity.
出处 《国际检验医学杂志》 CAS 2013年第3期296-297,299,共3页 International Journal of Laboratory Medicine
关键词 羟基胆骨化醇类 关节炎 类风湿 骨质疏松 骨密度 hydroxycholecalciferols arthritis,rheumatoid osteoporosis bone density
  • 相关文献

参考文献12

  • 1Bohler C,Radner H,Ernst M. Rheumatoid arthritis and falls:the influence of disease activity[J].Rheumatology(Oxford),2012,(05):234-239.
  • 2Drake M T,Khosla S. Male osteoporosis[J].Endocrinology and Metabolism Clinics of North America,2012,(03):629-641.
  • 3李锦(介评),曹峻岭(审校).血清甲状旁腺素、维生素D浓度及年龄与钙摄入的关系[J].国外医学(医学地理分册),2009,30(1):5-6. 被引量:2
  • 4Glossmann HH,Blumthaler M. Does rosuvastatin increase serum levels of 25-hydroxy-vitamin D[J].Dermatoendocrinol,2012,(01):2-7.
  • 5de Jong P,Weel A,de Man Y. To squeeze or not to squeeze,that′s the question!:Optimizing DAS28 by adding squeeze test of MTPs,in early RA[J].Arthritis and Rheumatism,2012,(06):102-111.
  • 6Ravindran J,Cavill C,Balakrishnan C. A modified Sharp score demonstrates disease progression in established psoriatic arthritis[J].Arthritis Care Res(Hoboken),2010,(01):86-91.
  • 7Kotani T,Takeuchi T,Takai S. Serum levels of matrix metalloproteinase(MMP) 9,a risk factor for acute coronary syndrome,are reduced independently of serum MMP-3 by anti-TNF-alpha antibody(infliximab) therapy in patients with rheumatoid arthritis[J].Journal of Pharmaceutical Sciences,2012,(11):864-871.
  • 8Rizzoli R,Adachi JD,Cooper C. Management of glucocorticoid-induced osteoporosis[J].Calcified Tissue International,2012,(02):783-788.
  • 9林燕萍,郭世明,吴银生,林煜,卢天祥,黄美雅,黄云梅.去卵巢骨质疏松模鼠DPD及1,25-(OH)_2D_3与骨质量的相关性研究[J].中国骨伤,2008,21(12):910-913. 被引量:8
  • 10Bone H. Future directions in osteoporosis therapeutics[J].Endocrinology and Metabolism Clinics of North America,2012,(03):655-661.

二级参考文献17

  • 1丁桂芝,刘忠厚,周勇.中西医结合防治骨质疏松症的基础与临床研究进展[J].中国骨质疏松杂志,1997,3(2):81-84. 被引量:121
  • 2林燕萍,周瑞祥,冯尔宥,黄美雅.健骨颗粒对去卵巢骨质疏松模型鼠钙调节激素的影响[J].中国骨伤,2005,18(1):22-24. 被引量:23
  • 3Toyras J,Nieminen MT, Kroger H, et al. Bone mineral density,ultrasound velocity,and broadband attenuation predict mechanical properties of trabecular bone differently. Bone ,2002,31 (4) :503- 507.
  • 4Swaminathan R. Biochemical markers of bone turnover. Clin Chim Aeta,2001,313(1-2) :95-105.
  • 5Legrand J J, Fisch C, Guillaumat PO, et al. Use of biochemical markers to monitor changes in bone turnover in cynomolgus monkeys. Biomarkers, 2003,8 ( 1 ) : 63-77.
  • 6Pidetcha P,Intramanee S,Patrakarn K,et al. Reference value for urinary deoxypyridinoline as a specific marker for measuring bone resorption in Thais. J Med Assoc Thai, 1999,82 ( 11 ) : 1136-1141.
  • 7Bettica P, Bevilacqua M,Vago T, et al. High prevalence of hypovitaminosis D among free-living postmenopausal women referred to an osteoporosis outpatient clinic in northern Italy for initial screening. Osteoporos Int, 1999,9 (3) :226-229.
  • 8Adami S, Viapiana O, Gatti D, et al. Relationship betweenserum parathyroid hormone, vitamin D sufficiency, age, and calcium intake[J]. Bone, 2008,42:267 - 270.
  • 9Steingrimsdottir L, Gunnarsson O, Indridason OS, et al. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake[J]. JAMA, 2005, 294: 2336-2341.
  • 10Sabota O, Mundey MK, San P, et al. Vitamin Dinsufficieney and the blunted PTH response in established osteoporosis: the role of magnesiumdefieiency[J]. Osteoporos Int, 2006, 17:1013 -1021.

共引文献11

同被引文献96

  • 1徐胜前,邵宜波,徐建华.类风湿性关节炎患者骨密度变化的临床研究[J].临床内科杂志,2004,21(11):763-765. 被引量:16
  • 2郭郡浩,姚茹冰,胡兵,刘玉秀,蔡辉.绝经后女性腰椎骨密度影响因素的多元线性回归分析[J].医学研究生学报,2007,20(9):961-962. 被引量:12
  • 3Lee SG, Park YE, Park SH, et al. Increased frequency of osteopo- rosis and BMD below the expected range for age among South Kore- an women with rheumatoid arthritis[ J]. Int J Rheum Dis, 2012, 15(3) : 289-296.
  • 4Kotani T ,Takeuchi T ,Takai S, et al. Serum levels of matrix metalio- proteinase(MMP) 9, a risk factor for acute coronary syndrome, are reduced independently of serum MMP-3 by anti-TNF-alpha anti- body (infliximab) therapy in patients with rheumatoid arthritis [ J ]. J Pharmacol Sci,2012,52( 11 ) :864-871.
  • 5Rizzoli R, Adachi JD, Cooper C, et al. Management of glucocorti- cold induced osteporosis [ J ]. Calcif Tissue Int, 2012,36 ( 2 ) : 783- 788.
  • 6Baron R.Osteoporosis in 2011:Osteoporosis therapy-dawn of the post-bisphosphonate era[J].Nat Rev Endo-crinol,2011,8(2):76-78.
  • 7Landete-Castillejos T,Molina-Quilez I,Estevez JA,et al.Alternative hypothesis for the origin of osteoporosis:therole of Mn[J].Front Biosci(Elite Ed),2012,4:1385-1389.
  • 8Brandi ML.An overview of osteoporosis:from genetics toclinics[J].Aging Clin Exp Res,2011,23(2 Suppl):3-5.
  • 9Nakashima K,Zhou X,Kunkel G,et al.The novel zinc fin-gercontaining transcription factor osterix is required forosteoblast differentiation and bone formation[J].Cell,2002,108(1):17-29.
  • 10Baek WY,de Crombrugghe B,Kim JE.Postnatally in-duced inactivation of Osterix in osteoblasts results in thereduction of bone formation and maintenance[J],Bone,2010,46(4):920-928.

引证文献8

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部